Small-Cell Breast Carcinoma with Response to Atezolizumab: A Case Report
- 28 April 2022
- journal article
- research article
- Published by Taylor & Francis in Immunotherapy
- Vol. 14 (9) , 669-674
Abstract
Background: Small-cell carcinoma of the breast is a rare disease with little research outlining molecular targets or optimal therapeutic management. We summarize a young female patient with poorly ... Plain language summary Immunotherapy is an emerging area in cancer research which utilizes the body's immune system to target cancerous cells. This offers oncologists an effective alternative to st...Keywords
This publication has 21 references indexed in Scilit:
- Immune Checkpoint Inhibitors in the Treatment of Patients with Neuroendocrine NeoplasiaOncology Research and Treatment, 2018
- Metastatic primary neuroendocrine carcinoma of the breast (NECB)Journal of Cancer Research and Practice, 2018
- Comprehensive clinical and molecular analyses of neuroendocrine carcinomas of the breastLaboratory Investigation, 2018
- Neuroendocrine Tumors of the BreastArchives of Pathology & Laboratory Medicine, 2017
- Checkpoint inhibitor is active against large cell neuroendocrine carcinoma with high tumor mutation burdenJournal for ImmunoTherapy of Cancer, 2017
- Primary neuroendocrine breast carcinomas are associated with poor local control despite favourable biological profile: a retrospective clinical studyBMC Cancer, 2017
- Primary small cell neuroendocrine carcinoma of the breast – A case report and review of the literatureInternational Journal of Surgery Case Reports, 2017
- Comparison of metastatic neuroendocrine neoplasms to the breast and primary invasive mammary carcinomas with neuroendocrine differentiationLaboratory Investigation, 2016
- Novel Mutations in Neuroendocrine Carcinoma of the BreastApplied Immunohistochemistry & Molecular Morphology, 2015
- Invasive neuroendocrine carcinoma of the breast: a population-based study from the surveillance, epidemiology and end results (SEER) databaseBMC Cancer, 2014